Perspective Therapeutics, Inc. Gross Profit

Quick Answer

Perspective Therapeutics, Inc. reported Gross Profit of $1.43 million for the year ending 2023.

  • This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
  • XBRL data for this metric is available from 2012 to 2023 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2012: $204.2 thousand | Q3 2012: -$20.4 thousand | Q4 2012: -$158.6 thousand | Q1 2013: $185.9 thousand | Q3 2013: -$77.3 thousand | Q4 2013: -$33.9 thousand | Q1 2014: $50.9 thousand | Q2 2014: -$136.2 thousand | Q3 2014: -$54.8 thousand | Q4 2014: -$38.0 thousand | Q1 2015: $55.2 thousand | Q2 2015: $205.0 thousand | Q3 2015: $83.0 thousand | Q4 2015: $30.0 thousand | Q1 2016: $66.0 thousand | Q2 2016: -$48.0 thousand | Q3 2016: $48.0 thousand | Q4 2016: -$1.0 thousand | Q1 2017: $293.0 thousand | Q2 2017: $498.0 thousand | Q3 2017: $265.0 thousand | Q4 2017: $531.0 thousand | Q1 2018: $609.0 thousand | Q2 2018: $443.0 thousand | Q3 2018: $524.0 thousand | Q4 2018: $765.0 thousand | Q1 2019: $879.0 thousand | Q2 2019: $879.0 thousand | Q3 2019: $1.24 million | Q4 2019: $1.11 million | Q1 2020: $1.71 million | Q2 2020: $1.07 million | Q3 2020: $1.25 million | Q4 2020: $1.17 million | Q1 2021: $1.36 million | Q2 2021: $1.35 million | Q3 2021: $1.03 million | Q4 2021: $1.22 million | Q1 2022: $1.44 million | Q2 2022: $926.0 thousand | Q3 2022: $414.0 thousand | Q1 2023: $487.0 thousand | Q2 2023: $248.0 thousand | Q3 2023: $738.0 thousand.
  • Over the full 13 years of available data (2012 to 2023), Perspective Therapeutics, Inc.'s Gross Profit has grown by 103.9%.
  • Historical annual values: Fiscal year 2023: $1.43 million | Fiscal year 2022: $0.00 | Fiscal year 2022: $0.00 | Fiscal year 2021: $5.12 million | Fiscal year 2020: $5.12 million | Fiscal year 2019: $3.05 million | Fiscal year 2018: $1.84 million | Fiscal year 2017: $838.0 thousand | Fiscal year 2016: $129.0 thousand | Fiscal year 2015: $167.0 thousand | Fiscal year 2014: -$196.5 thousand | Fiscal year 2013: $150.2 thousand | Fiscal year 2012: $703.2 thousand.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: